Template:PDB Gallery/1398

• 
  1b07: CRK SH3 DOMAIN COMPLEXED WITH PEPTOID INHIBITOR
• 
  1cka: STRUCTURAL BASIS FOR THE SPECIFIC INTERACTION OF LYSINE-CONTAINING PROLINE-RICH PEPTIDES WITH THE N-TERMINAL SH3 DOMAIN OF C-CRK
• 
  1ckb: STRUCTURAL BASIS FOR THE SPECIFIC INTERACTION OF LYSINE-CONTAINING PROLINE-RICH PEPTIDES WITH THE N-TERMINAL SH3 DOMAIN OF C-CRK
• 
  1ju5: Ternary complex of an Crk SH2 domain, Crk-derived phophopeptide, and Abl SH3 domain by NMR spectroscopy
• 
  1m30: Solution structure of N-terminal SH3 domain from oncogene protein c-Crk
• 
  1m3a: Solution structure of a circular form of the truncated N-terminal SH3 domain from oncogene protein c-Crk.
• 
  1m3b: Solution structure of a circular form of the N-terminal SH3 domain (A134C, E135G, R191G mutant) from oncogene protein c-Crk.
• 
  1m3c: Solution structure of a circular form of the N-terminal SH3 domain (E132C, E133G, R191G mutant) from oncogene protein c-Crk
• 
  2dvj: phosphorylated Crk-II
• 
  2eyv: SH2 domain of CT10-Regulated Kinase
• 
  2eyw: N-terminal SH3 domain of CT10-Regulated Kinase
• 
  2eyx: C-Terminal SH3 domain of CT10-Regulated Kinase
• 
  2eyy: CT10-Regulated Kinase isoform I
• 
  2eyz: CT10-Regulated Kinase isoform II
• 
  2ggr: Solution structure of the C-terminal SH3 domain of c-CrkII